These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6072311)

  • 1. Pneumonic plague in an untreated plague-vaccinated individual.
    Cohen RJ; Stockard JL
    JAMA; 1967 Oct; 202(4):365-6. PubMed ID: 6072311
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of live or killed plague vaccines in man.
    Meyer KF
    Bull World Health Organ; 1970; 42(5):653-66. PubMed ID: 4988692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical aspects and diagnostics of plague].
    Velimirovic B
    Z Tropenmed Parasitol; 1973 Mar; 24(1):96-104. PubMed ID: 4733217
    [No Abstract]   [Full Text] [Related]  

  • 4. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VI. Plague. Epidemiology.
    Henderson RJ
    Trop Dis Bull; 1972 Jul; 69(7):585-92. PubMed ID: 5069999
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.
    Fellows P; Price J; Martin S; Metcalfe K; Krile R; Barnewall R; Hart MK; Lockman H
    Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alexandre Yersin and the plague bacillus.
    Solomon T
    J Trop Med Hyg; 1995 Jun; 98(3):209-12. PubMed ID: 7783282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behaviour in vivo of Pasteurella pestis: antigens and antibodies in the pneumonic plague].
    Barber C; Eylan E; Ben-Efraim S
    Rev Immunol (Paris); 1972; 36(4):155-62. PubMed ID: 4667162
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).
    Fellows P; Adamovicz J; Hartings J; Sherwood R; Mega W; Brasel T; Barr E; Holland L; Lin W; Rom A; Blackwelder W; Price J; Morris S; Snow D; Hart MK
    Vaccine; 2010 Nov; 28(49):7748-56. PubMed ID: 20920572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and epidemiologic notes on a defined outbreak of plague in Vietnam.
    Legters LJ; Cottingham AJ; Hunter DH
    Am J Trop Med Hyg; 1970 Jul; 19(4):639-52. PubMed ID: 5425503
    [No Abstract]   [Full Text] [Related]  

  • 12. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
    FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary pneumonic plague contracted from a mountain lion carcass.
    Wong D; Wild MA; Walburger MA; Higgins CL; Callahan M; Czarnecki LA; Lawaczeck EW; Levy CE; Patterson JG; Sunenshine R; Adem P; Paddock CD; Zaki SR; Petersen JM; Schriefer ME; Eisen RJ; Gage KL; Griffith KS; Weber IB; Spraker TR; Mead PS
    Clin Infect Dis; 2009 Aug; 49(3):e33-8. PubMed ID: 19555287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the efficacy of vaccination in affording protection against plague.
    Williams JE; Cavanaugh DC
    Bull World Health Organ; 1979; 57(2):309-13. PubMed ID: 312163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
    Reed DS; Martinez MJ
    Vaccine; 2006 Mar; 24(13):2283-9. PubMed ID: 16377037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early serological non-response in human plague infections.
    Marshall JD; Gibson FL; Dung TC; Quy DV
    Bull World Health Organ; 1967; 37(3):495-7. PubMed ID: 5301390
    [No Abstract]   [Full Text] [Related]  

  • 18. Serological studies on human plague in Southern Africa. Part II. A bubonic/pneumonic plague epidemic in Lesotho.
    Isaäcson M; Qhobela QM; Davis DH; Growngold TP
    S Afr Med J; 1976 Jun; 50(24):929-32. PubMed ID: 935988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A filtered non-toxic plague vaccine which protects guinea-pigs and mice.
    Smith H; Packman LP
    Br J Exp Pathol; 1966 Feb; 47(1):25-34. PubMed ID: 5908699
    [No Abstract]   [Full Text] [Related]  

  • 20. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis).
    Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE
    Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.